Acute biphenotypic leukaemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Acute biphenotypic leukaemia Classification and external resources | |
| ICD-O: | 9805/3 |
|---|---|
| MeSH | D015456 |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Acute biphenotypic leukaemia is a form of leukaemia where the lineage is of both lymphoid and myeloid origin.[1][1]
References
WikiDoc Research Resources for Acute biphenotypic leukaemia (Click show to right to view) | |
|---|---|
| Articles on Acute biphenotypic leukaemia | Most recent articles on Acute biphenotypic leukaemia • Most cited articles on Acute biphenotypic leukaemia • Review articles on Acute biphenotypic leukaemia • Articles on Acute biphenotypic leukaemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Acute biphenotypic leukaemia | Powerpoint slides on Acute biphenotypic leukaemia • Images of Acute biphenotypic leukaemia • Photos of Acute biphenotypic leukaemia • Podcasts & MP3s on Acute biphenotypic leukaemia • Videos on Acute biphenotypic leukaemia |
| Evidence Based Medicine Regarding Acute biphenotypic leukaemia | Cochrane Collaboration on Acute biphenotypic leukaemia • Bandolier on Acute biphenotypic leukaemia • TRIP on Acute biphenotypic leukaemia |
| Cost Effectiveness of Acute biphenotypic leukaemia | Cost Effectiveness of Acute biphenotypic leukaemia |
| Clinical Trials Involving Acute biphenotypic leukaemia | Ongoing Trials on Acute biphenotypic leukaemia at Clinical Trials.gov • Trial results on Acute biphenotypic leukaemia • Clinical Trials on Acute biphenotypic leukaemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Acute biphenotypic leukaemia | US National Guidelines Clearinghouse on Acute biphenotypic leukaemia • NICE Guidance on Acute biphenotypic leukaemia • NHS PRODIGY Guidance • FDA on Acute biphenotypic leukaemia • CDC on Acute biphenotypic leukaemia |
| Textbook Information on Acute biphenotypic leukaemia | Books and Textbook Information on Acute biphenotypic leukaemia |
| Pharmacology Resources on Acute biphenotypic leukaemia | Dosing of Acute biphenotypic leukaemia • Drug interactions with Acute biphenotypic leukaemia • Side effects of Acute biphenotypic leukaemia • Allergic reactions to Acute biphenotypic leukaemia • Overdose information on Acute biphenotypic leukaemia • Carcinogenicity information on Acute biphenotypic leukaemia • Acute biphenotypic leukaemia in pregnancy • Pharmacokinetics of Acute biphenotypic leukaemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Acute biphenotypic leukaemia | Genetics of Acute biphenotypic leukaemia • Pharmacogenomics of Acute biphenotypic leukaemia • Proteomics of Acute biphenotypic leukaemia |
| Newstories on Acute biphenotypic leukaemia | Acute biphenotypic leukaemia in the news • Be alerted to news on Acute biphenotypic leukaemia • News trends on Acute biphenotypic leukaemia |
| Commentary on Acute biphenotypic leukaemia | Blogs on Acute biphenotypic leukaemia |
| Patient Resources on Acute biphenotypic leukaemia | Patient resources on Acute biphenotypic leukaemia • Discussion groups on Acute biphenotypic leukaemia • Patient Handouts on Acute biphenotypic leukaemia • Directions to Hospitals Treating Acute biphenotypic leukaemia • Risk calculators and risk factors for Acute biphenotypic leukaemia |
| Healthcare Provider Resources on Acute biphenotypic leukaemia | Symptoms of Acute biphenotypic leukaemia • Causes & Risk Factors for Acute biphenotypic leukaemia • Diagnostic studies for Acute biphenotypic leukaemia • Treatment of Acute biphenotypic leukaemia |
| Continuing Medical Education (CME) Programs on Acute biphenotypic leukaemia | CME Programs on Acute biphenotypic leukaemia |
| International Resources on Acute biphenotypic leukaemia | Acute biphenotypic leukaemia en Espanol • Acute biphenotypic leukaemia en Francais |
| Business Resources on Acute biphenotypic leukaemia | Acute biphenotypic leukaemia in the Marketplace • Patents on Acute biphenotypic leukaemia |
| Informatics Resources on Acute biphenotypic leukaemia | List of terms related to Acute biphenotypic leukaemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
